NewslettersDermal Cell News Identification and Characterization of a New Potent Inhibitor Targeting CtBP1/BARS in Melanoma Cells By Emily Salmini - May 7, 2024 0 Researchers identified a potent and selective inhibitor of C-terminal-binding protein 1/brefeldin A ADP-ribosylation substrate (CtBP1/BARS) active in cellular and melanoma animal models. [Journal Of Experimental & Clinical Cancer Research] Full Article